About Us
For Sponsors
For Researchers
Conditions
ADHD
ALS
Asthma
Autism
Eczema
IVF
MDS
Osteoarthritis
Psoriasis
Rheumatoid Arthritis
Treatments
Contrave
Dsuvia
Epidiolex
Ibrutinib
Kybella
Platelet-Rich Plasma
Testosterone
Xarelto
Xiidra
Yondelis
Cities
Anaheim, CA
Baltimore, MD
Boston, MA
Chicago, IL
High Point, NC
Houston, TX
Las Vegas, NV
Los Angeles, CA
Miami, FL
San Diego, CA
States
Colorado
Florida
Indiana
Maine
Massachusetts
Michigan
New York
Ohio
Pennsylvania
Texas
Metastatic Prostate Cancer Clinical Trials 2022
Metastatic Prostate Cancer studies recruiting patients for novel treatments. Filter by phase, distance, and inclusion criteria to find your perfect metastatic prostate cancer clinical trial in 2022.
Condition
Metastatic Prostate Cancer
Location
Distance
10 Miles
Any
Age
Search
Clinical Trials
Metastatic Prostate Cancer Clinical Trials 2022
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
ORIC-944
for refractory, metastatic hormone-refractory Prostate cancer
Detroit, MI
18+
Male
Phase 1
Recruiting
Metastatic
Detroit, MI
18+
Male
The purpose of this study is to establish recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD) and preliminary antitumor activity of ORIC-944 in patients with metastatic prostate cancer.
Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Abiraterone
for Prostate Cancer
La Jolla, CA
18+
Male
Phase 2
Waitlist Available
Metastatic
La Jolla, CA
18+
Male
This is a phase 2, multicenter, open-label study to evaluate the efficacy of abivertinib with abiraterone in patients with metastatic castration-resistant prostate cancer.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
High Intensity Interval Training
for Metastatic Prostate Adenocarcinoma
San Antonio, TX
18+
Male
Recruiting
Metastatic
San Antonio, TX
18+
Male
This study aims to examine the use of high-intensity interval training (HIIT) and resistance training on docetaxel chemotherapy tolerability and toxicity in metastatic prostate cancer.
Phase-Based Progress Estimates
2
Effectiveness
3
Safety
Talazoparib Plus Enzalutamide
for Prostate Cancer
Chicoutimi, Canada
18+
Male
Phase 3
Recruiting
Metastatic
Chicoutimi, Canada
18+
Male
This study is evaluating whether a drug may help treat prostate cancer.
Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Olaparib
for Prostate Cancer
Ann Arbor, MI
18+
Male
Phase 2
Recruiting
Metastatic
Ann Arbor, MI
18+
Male
This study is evaluating whether radiation therapy with hormone therapy (ADT) and chemotherapy is safe and effective for men with prostate cancer.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
SBRT
for Prostate Cancer
Toronto, Canada
18+
Male
Phase 1 & 2
Recruiting
Metastatic
Toronto, Canada
18+
Male
This study is evaluating whether a new type of radiotherapy called stereotactic radiotherapy (SBRT) can be used to treat prostate cancer.
Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Apalutamide
for Prostate Cancer
Hialeah, FL
18+
Male
Phase 2
Waitlist Available
High Risk
Hialeah, FL
18+
Male
Main Study: The purpose of main study is to assess if the combination of apalutamide and androgen deprivation therapy (ADT) in participants with high-risk localized prostate cancer improves the biochemical recurrence (BCR) free rate. Sub-study: The purpose of the sub-study is to assess if the co administration of apalutamide and relugolix is able to maintain castrate levels of testosterone.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
7 Tesla Magnetic Resonance Imaging
for Stage IIB Prostate Cancer AJCC v8
Los Angeles, CA
18+
Male
Recruiting
Metastatic
Los Angeles, CA
18+
Male
This study is evaluating whether 7 Tesla MRI may help doctors learn if patients with prostate cancer that has not spread to other places in the body (non-metastatic) and who have or
Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Stereotactic Ablative Radiotherapy (SABR)
for Prostate Cancer
Baltimore, MD
18+
Male
Phase 2
Recruiting
Metastatic
Baltimore, MD
18+
Male
This study is evaluating whether a radioactive drug may help treat prostate cancer.
Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Hydroxychloroquine Sulfate 200Mg Tab
for Prostate Cancer
Lexington, KY
18+
Male
Phase 2
Recruiting
Metastatic
Lexington, KY
18+
Male
Treatment of recurrent oligometastatic prostate cancer may be enhanced by the addition of Hydroxychloroquine to the current treatment regimens. Potential benefits of Hydroxychloroquine include delayed disease progression and delayed initiation of androgen deprivation therapy (ADT), thus lessening morbidity, distressing side effects, and improving functioning and quality of life in men with recurrent prostate cancer. Building on prior research at Markey, patients recently diagnosed with recurrent oligometastatic prostate cancer will be approached about participating in this study. Per standard of care, these patients undergo either surgery or radiation, in addition participants of this clinical trial will also receive Hydroxychloroquine (400 mg per day, oral medication) for 3 months. It is expected that a participant will exhibit a 50% increase of tumor suppressor PAR-4, as well as few, if any, negative side effects from Hydroxychloroquine.
Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Apalutamide
for Stage IVB Prostate Cancer AJCC v8
Los Angeles, CA
18+
Male
Phase 2
Recruiting
Metastatic
Los Angeles, CA
18+
Male
This study is evaluating whether antiandrogen therapy and SBRT work better than SBRT alone in treating patients with prostate cancer that has come back and has spread to other parts of the body.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Standard Of Care
for refractory, metastatic hormone-refractory Prostate cancer
Toronto, Canada
18+
Male
Recruiting
Metastatic
Toronto, Canada
18+
Male
This study is evaluating whether surgery or radiation therapy is better than standard treatments for prostate cancer.
Phase-Based Progress Estimates
2
Effectiveness
3
Safety
Niraparib
for Castration Resistant Prostatic Cancer
Springfield, OR
18+
Male
Phase 3
Waitlist Available
Metastatic
Springfield, OR
18+
Male
This study is evaluating whether a drug called niraparib may help treat advanced prostate cancer.
Phase-Based Progress Estimates
2
Effectiveness
3
Safety
Degarelix
for Prostate Cancer
Troy, MI
18+
Male
Phase 3
Recruiting
Grade I
Troy, MI
18+
Male
This study is evaluating whether a surgery or radiation therapy may help treat prostate cancer.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Grape Seed Extract
for Prostate Cancer
Aurora, CO
18+
Male
Recruiting
Metastatic
Aurora, CO
18+
Male
This study is evaluating whether a dietary supplement may help reduce the symptoms of ulcerative colitis.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Pembrolizumab
for Adenocarcinoma, Prostate
Madison, WI
18+
Male
Phase 1 & 2
Waitlist Available
Grade II
Madison, WI
18+
Male
This study is evaluating whether a vaccine and a monoclonal antibody can kill more tumor cells than either one alone.
Phase-Based Progress Estimates
2
Effectiveness
3
Safety
LHRHA Or Surgical Castration
for Prostate Cancer
Saint John, Canada
18+
Male
Phase 3
Waitlist Available
Metastatic
Saint John, Canada
18+
Male
This study is evaluating whether a new drug called enzalutamide is more effective than a conventional drug called flutamide when used as first line androgen deprivation therapy (ADT) for newly diagnosed metastatic prostate cancer.
Phase-Based Progress Estimates
2
Effectiveness
3
Safety
TAK-700
for Prostate Cancer
Washington, United States
18+
Male
Phase 3
Waitlist Available
Metastatic
Washington, United States
18+
Male
This study is evaluating whether a new drug called TAK-700 can improve survival in men with metastatic prostate cancer.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
89Zr-DFO-huJ591
for Prostate Cancer
New York, NY
18+
Male
Phase 1 & 2
Waitlist Available
Metastatic
New York, NY
18+
Male
This study is evaluating whether a new kind of scan can find cancer cells in the body.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Engineered Autologous T Cells
for Prostate Cancer
New York, NY
18+
Male
Phase 1
Waitlist Available
Metastatic
New York, NY
18+
Male
This study is evaluating whether a weakened virus can be used to change the patients own immune cells so that they can recognize and kill the cancer cells.
Phase-Based Progress Estimates
2
Effectiveness
3
Safety
Androgen-deprivation Therapy
for Hypersensitivity
Oconto Falls, WI
18+
Male
Phase 3
Waitlist Available
Metastatic
Oconto Falls, WI
18+
Male
This study is evaluating whether androgen-ablation therapy and chemotherapy are more effective than androgen-ablation therapy alone in treating patients with metastatic prostate cancer.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Positron Emission Tomography
for Prostate Cancer
New York, NY
Any Age
Male
Waitlist Available
Metastatic
New York, NY
Any Age
Male
This study is evaluating whether a PET scan can improve the ability to detect new or recurrent prostate cancer.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
11C-YJH08
for Stage IV Prostate Cancer AJCC v8
San Francisco, CA
18+
Male
Phase 1
Recruiting
Metastatic
San Francisco, CA
18+
Male
This study is evaluating if PET imaging using 11C-YJH08 can be useful for detecting certain cell receptor expression in tumor cells in patients with prostate cancer that has spread to other parts of the body (metastatic).
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stereotactic Body Radiation Therapy (SABR)
for Prostate Cancer
Toronto, Canada
18+
Male
Recruiting
Metastatic
Toronto, Canada
18+
Male
This study is evaluating whether stereotactic ablative body radiotherapy can be used to treat oligoprogressive metastases in men with prostate cancer.
Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Carboplatin
for Aggression
Durham, NC
18+
Male
Phase 2
Recruiting
Metastatic
Durham, NC
18+
Male
This study is evaluating whether a combination of drugs may help treat aggressive forms of prostate cancer.
1
2
3
Other Trials to Consider
89Zr-DFO-YS5
for Prostate Cancer
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Phase 1
Recruiting
Metastatic
San Francisco, CA
18+
All Sexes
AC176
for Prostate Cancer
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Phase 1
Recruiting
Locally Advanced
Sarasota, FL
18+
Male
Poly-ICLC (Cohort B)
for Prostate Cancer
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Phase 1
Recruiting
Metastatic
Houston, TX
18+
Male
ARV-766
for Prostate Cancer
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Phase 1
Recruiting
Metastatic
Buffalo, NY
18+
Male
Cemiplimab
for Metastatic Castration-resistant Prostate Cancer
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Phase 1 & 2
Recruiting
Metastatic
Philadelphia, PA
18+
Male
Cirmtuzumab
for Prostate Cancer
Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Phase 2
Waitlist Available
Metastatic
La Jolla, CA
18+
Male
SRF617
for Prostate Cancer
Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Phase 2
Recruiting
Metastatic
San Antonio, TX
18+
Male
ARV-110
for Prostate Cancer
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Phase 1 & 2
Recruiting
Locally Advanced
Salt Lake City, UT
18+
Male
LAVA-1207
for Metastatic Castration Resistant Prostate Cancer (CRPC)
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Phase 1 & 2
Recruiting
Metastatic
New York, NY
18+
Male
NOX66
for Prostate Cancer
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Phase 1 & 2
Recruiting
Metastatic
Beverly Hills, CA
18+
All Sexes
Capivasertib
for Prostate Cancer
Phase-Based Progress Estimates
2
Effectiveness
3
Safety
Phase 3
Recruiting
Metastatic
Watertown, SD
18+
Male
Docetaxel
for refractory, metastatic hormone-refractory Prostate cancer
Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Phase 2
Recruiting
Metastatic
New York, NY
18+
Male
XmAb20717 + Carboplatin + Cabazitaxel
for Prostate Cancer
Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Phase 2
Recruiting
Metastatic
Albuquerque, NM
18+
Male
Consultation Audio Recording App
for Prostate Cancer
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Recruiting
Locally Advanced
San Francisco, CA
18+
Male
High Intensity Interval Training
for Metastatic Prostate Adenocarcinoma
Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Recruiting
Metastatic
San Antonio, TX
18+
Male
Popular Categories
Top 10 Prostate Cancer Clinical Trials
Prostate Cancer Clinical Trials 2022
Top 10 Triple Negative Breast Cancer Clinical Trials
Triple Negative Breast Cancer Clinical Trials 2022
Top 10 Esophageal Cancer Clinical Trials
Esophageal Cancer Clinical Trials 2022
Top 10 Cervical Cancer Clinical Trials
Cervical Cancer Clinical Trials 2022
Top 10 Liver Cancer Clinical Trials
Liver Cancer Clinical Trials 2022
Top 10 Advanced Prostate Cancer Clinical Trials
Advanced Prostate Cancer Clinical Trials 2022
Top 10 Colorectal Cancer Clinical Trials
Colorectal Cancer Clinical Trials 2022
Top 10 Rectal Cancer Clinical Trials
Rectal Cancer Clinical Trials 2022
Top 10 Anaplastic Thyroid Cancer Clinical Trials
Anaplastic Thyroid Cancer Clinical Trials 2022
Top 10 Bone Cancer Clinical Trials
Bone Cancer Clinical Trials 2022
Top 10 Prostate Clinical Trials
Prostate Clinical Trials 2022
Top 10 Medullary Thyroid Cancer Clinical Trials
Medullary Thyroid Cancer Clinical Trials 2022
Top 10 Recurrent Prostate Cancer Clinical Trials
Recurrent Prostate Cancer Clinical Trials 2022
Best 10 BC Prostate Cancer Clinical Trials
Prostate Cancer Trials in British Columbia
Best 10 Canadian Prostate Cancer Clinical Trials
Prostate Cancer Trials in Canada
Relevant Clinical Trials
Cancer Clinical Trials 2022
Pancreas Cancer Clinical Trials 2022
Prostate Cancer Clinical Trials 2022
Breast Cancer Clinical Trials 2022
Oncology Clinical Trials 2022
Pancreatic Cancer Clinical Trials 2022
Melanoma Clinical Trials 2022
Multiple Myeloma Clinical Trials 2022
Triple Negative Breast Cancer Clinical Trials 2022
Ovarian Cancer Clinical Trials 2022
Lung Cancer Clinical Trials 2022
Colon Cancer Clinical Trials 2022
CLL Clinical Trials 2022
Small Cell Lung Cancer Clinical Trials 2022
Esophageal Cancer Clinical Trials 2022
Mesothelioma Clinical Trials 2022
Leukemia Clinical Trials 2022
AML Clinical Trials 2022
Bladder Cancer Clinical Trials 2022
Cholangiocarcinoma Clinical Trials 2022
Top Oncology Trials
Brain Cancer Clinical Trials 2022
Cervical Cancer Clinical Trials 2022
Glioblastoma Clinical Trials 2022
Metastatic Breast Cancer Clinical Trials 2022
Liver Cancer Clinical Trials 2022
Advanced Prostate Cancer Clinical Trials 2022
Brain Tumor Clinical Trials 2022
Sarcoma Clinical Trials 2022
Colorectal Cancer Clinical Trials 2022
Bile Duct Cancer Clinical Trials 2022
Osteosarcoma Clinical Trials 2022
Kidney Cancer Clinical Trials 2022
Gastric Cancer Clinical Trials 2022
Thyroid Cancer Clinical Trials 2022
Glioblastoma Multiforme Clinical Trials 2022
Neuroblastoma Clinical Trials 2022
HCC Clinical Trials 2022
NSCLC Clinical Trials 2022
Head and Neck Cancer Clinical Trials 2022
Myeloma Clinical Trials 2022
Popular Clinical Trials
COVID Clinical Trials 2022
Depression Clinical Trials 2022
ALS Clinical Trials 2022
Coronavirus Clinical Trials 2022
IVF Clinical Trials 2022
Marijuana Clinical Trials 2022
Type 1 Diabetes Clinical Trials 2022
Lupus Clinical Trials 2022
Tinnitus Clinical Trials 2022
PTSD Clinical Trials 2022
Diabetes Clinical Trials 2022
Rheumatoid Arthritis Clinical Trials 2022
Psoriasis Clinical Trials 2022
Multiple Sclerosis Clinical Trials 2022
Obesity Clinical Trials 2022
Psilocybin Clinical Trials 2022
Weight Loss Clinical Trials 2022
Osteoarthritis Clinical Trials 2022
Lyme Disease Clinical Trials 2022
Retinitis Pigmentosa Clinical Trials 2022
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
461 2nd St., San Francisco, CA
hello@withpower.com
(415) 900-4227
About Us
Join The Team!
Conditions
ADHD
ALS
Asthma
Autism
Eczema
IVF
MDS
Osteoarthritis
Psoriasis
Rheumatoid Arthritis
Locations
Colorado
Florida
Indiana
Maine
Massachusetts
Michigan
New York
Ohio
Pennsylvania
Texas
Cancer Related
Chronic Lymphocytic Leukemia
Esophageal
Leukemia
Lymphoma
Melanoma
Multiple Myeloma
Pancreatic Cancer
Prostate Cancer
Small Cell Lung Cancer
Triple Negative Breast Cancer
Treatments
Contrave
Dsuvia
Epidiolex
Ibrutinib
Kybella
Platelet-Rich Plasma
Testosterone
Xarelto
Xiidra
Yondelis
Cities
Anaheim, CA
Baltimore, MD
Boston, MA
Chicago, IL
High Point, NC
Houston, TX
Las Vegas, NV
Los Angeles, CA
Miami, FL
San Diego, CA
Terms of Service
Privacy Policy